Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. In the eye and in the lung, our layer of protective mucus plays an important role in keeping our bodies healthy. Sometimes though, either through genetics, aging or environmental stimulus, our innate mucosal defense system can become compromised. Parion’s science driven technologies target respiratory and ocular diseases in which the patient’s ability to protect their mucosal surfaces is compromised.
Looking for a particular Parion Sciences employee's phone or email?
The Parion Sciences annual revenue was $5.3 million in 2026.
Paul Boucher is the CEO and President of Parion Sciences.
9 people are employed at Parion Sciences.
Parion Sciences is based in Durham, North Carolina.
The NAICS codes for Parion Sciences are [32541, 325, 32, 3254].
The SIC codes for Parion Sciences are [28, 283].